|
MechanismSARS-CoV-2 S protein neutralization |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Hua Bio Co., Ltd
0 Patents (Medical) associated with Hua Bio Co., Ltd
100 Deals associated with Hua Bio Co., Ltd
100 Translational Medicine associated with Hua Bio Co., Ltd